InvestorsHub Logo
Followers 30
Posts 2195
Boards Moderated 0
Alias Born 12/13/2016

Re: nidan7500 post# 117749

Tuesday, 08/29/2017 4:00:29 PM

Tuesday, August 29, 2017 4:00:29 PM

Post# of 462172
Nidan, I'm no expert in unfriendly takeovers but, I don't think that the FDA will mettle in the business aspects of its clients and Congress seems to be far more influenced by the size and capital of its business constituents. What would it take to shake loose enough shares to get control of the company or at least a major voting share.....$50 , $70, $100/share offer. At 60M shares (with warrants and options) thats a $3 to 6B offer....well within Biogen's M&A budget. Could retail buy enough shares under the protection plan to make a difference? And what would the institutions do in the face of 1000-2000% profits?

Maybe those on the board who have witnessed the "hostile takeover" scenario would care to comment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News